Showing all 4 results
Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization. Zonisamide Capsules
FreeZonisamide capsules are antiepileptic medications used as adjunctive therapy for adults and adolescents with partial-onset seizures. They are chemically classified as sulfonamides.





